Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SNX9 mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of SNX9 mRNA | CTD | PMID:17555576 | 17beta-estradiol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNX9 mRNA | CTD | PMID:21570461 | 2,4,6-tribromophenol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2-hydroxypropanoic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SNX9 mRNA | CTD | PMID:26251327 | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Oxazolone results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of SNX9 mRNA | CTD | PMID:19770486 | arsenite(3-) | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SNX9 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | affects methylation | ISO | SNX9 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNX9 intron and Benzo(a)pyrene affects the methylation of SNX9 promoter | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | benzoates | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Benzoates analog results in increased expression of SNX9 mRNA | CTD | PMID:29472718 | bisphenol A | increases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SNX9 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of SNX9 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of SNX9 protein | CTD | PMID:33376534 | bisphenol A | decreases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SNX9 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | ISO | Snx9 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of SNX9 gene | CTD | PMID:28505145 | Bisphenol B | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of SNX9 protein | CTD | PMID:34186270 | caffeine | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of SNX9 protein | CTD | PMID:35688186 | calcitriol | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SNX9 mRNA | CTD | PMID:16002434 | CGP 52608 | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SNX9 gene] | CTD | PMID:28238834 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SNX9 mRNA | CTD | PMID:20938992 | copper(II) sulfate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SNX9 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of SNX9 protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | coumestrol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | crocidolite asbestos | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Asbestos and Crocidolite affects the expression of SNX9 mRNA | CTD | PMID:24160326 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SNX9 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SNX9 mRNA | CTD | PMID:20106945 and PMID:25562108 | dextran sulfate | decreases expression | EXP | | 6480464 | Dextran Sulfate results in decreased expression of SNX9 protein | CTD | PMID:32272095 | dextran sulfate | multiple interactions | EXP | | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SNX9 protein] | CTD | PMID:32272095 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SNX9 mRNA | CTD | PMID:21266533 | Enterolactone | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | ethanol | decreases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | Ethanol results in decreased expression of SNX9 protein | CTD | PMID:20133374 | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of SNX9 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SNX9 mRNA | CTD | PMID:20938992 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of SNX9 protein | CTD | PMID:37730182 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX9 mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SNX9 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SNX9 mRNA | CTD | PMID:20938992 | menadione | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of SNX9 mRNA | CTD | PMID:20044591 | methidathion | increases expression | EXP | | 6480464 | methidathion results in increased expression of SNX9 mRNA | CTD | PMID:34813904 | nickel sulfate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | nimesulide | decreases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of SNX9 mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | ISO | Snx9 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX9 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SNX9 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SNX9 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX9 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SNX9 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of SNX9 mRNA | CTD | PMID:19159669 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SNX9 mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | potassium dichromate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of SNX9 protein | CTD | PMID:23718831 | pyrogallol | increases expression | EXP | | 6480464 | Pyrogallol results in increased expression of SNX9 mRNA | CTD | PMID:20362636 | rac-lactic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:30851411 | serpentine asbestos | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Asbestos and Serpentine affects the expression of SNX9 mRNA | CTD | PMID:24160326 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SNX9 mRNA | CTD | PMID:36209798 | Soman | increases expression | ISO | Snx9 (Rattus norvegicus) | 6480464 | Soman results in increased expression of SNX9 mRNA | CTD | PMID:19281266 | testosterone | affects expression | EXP | | 6480464 | Testosterone affects the expression of SNX9 mRNA | CTD | PMID:20403060 | thimerosal | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SNX9 mRNA | CTD | PMID:27188386 | topotecan | multiple interactions | ISO | Snx9 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX9 mRNA | CTD | PMID:25729387 | urethane | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Urethane results in increased expression of SNX9 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SNX9 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SNX9 gene | CTD | PMID:29154799 | vorinostat | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SNX9 mRNA | CTD | PMID:27188386 | |